Brief: Alligator Bioscience Q2 Operating Loss At SEK 34.5 Mln
July 13 (Reuters) - Alligator Bioscience AB ATORX.ST :
* APRIL-JUNE 2021 NET SALES, SEK 3.8 MILLION (4.4)
* Q2 OPERATING RESULT, SEK -34.5 MILLION (-34.7)
Source text for Eikon: ID:nWkr9gJWXL
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue